Author:
Timmen Melanie,Hidding Heriburg,Götte Martin,Khassawna Thaqif El,Kronenberg Daniel,Stange Richard
Abstract
AbstractThe heparan sulfate proteoglycan Syndecan-1, a mediator of signals between the extracellular matrix and cells involved is able to interact with OPG, one of the major regulators of osteoclastogenesis. The potential of osteoblasts to induce osteoclastogenesis is characterized by a switch of OPG (low osteoclastogenic potential) towards RANKL production (high osteoclastogenic potential). In the present study, we investigated the influence of endogenous Syndecan-1 on local bone-cell-communication via the RANKL/OPG-axis in murine osteoblasts and osteoclasts in wild type and Syndecan-1 lacking cells. Syndecan-1 expression and secretion was increased in osteoblasts with high osteoclastogenic potential. Syndecan-1 deficiency led to increased OPG release by osteoblasts that decreased the availability of RANKL. In co-cultures of Syndecan-1 deficient osteoblasts with osteoclast these increased OPG in supernatant caused decreased development of osteoclasts. Syndecan-1 and RANKL level were increased in serum of aged WT mice, whereas Syndecan-1 deficient mice showed high serum OPG concentration. However, bone structure of Syndecan-1 deficient mice was not different compared to wild type. In conclusion, Syndecan-1 could be regarded as a new modulator of bone-cell-communication via RANKL/OPG axis. This might be of high impact during bone regeneration or bone diseases like cancer where Syndecan-1 expression is known to be even more prevalent.
Funder
Deutsche Forschungsgemeinschaft
Projekt DEAL
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Bernfield, M., Hinkes, M. T. & Gallo, R. L. Developmental expression of the syndecans: possible function and regulation. Development (Cambridge, England) 119, 205–212 (1993).
2. Rapraeger, A., Jalkanen, M., Endo, E., Koda, J. & Bernfield, M. The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans. J. Biol. Chem. 260, 11046–11052 (1985).
3. Sanderson, R. D., Yang, Y., Suva, L. J. & Kelly, T. Heparan sulfate proteoglycans and heparanase—partners in osteolytic tumor growth and metastasis. Matrix Biol. 23, 341–352. https://doi.org/10.1016/j.matbio.2004.08.004 (2004).
4. Dhodapkar, M. V. et al. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation. Blood 91, 2679–2688 (1998).
5. Teng, Y. H., Aquino, R. S. & Park, P. W. Molecular functions of syndecan-1 in disease. Matrix Biol. 31, 3–16. https://doi.org/10.1016/j.matbio.2011.10.001S0945-053X(11)00103-X[pii] (2012).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献